Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 388
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Am Acad Dermatol ; 90(2): 319-327, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37879460

ABSTRACT

BACKGROUND: Isothiazolinones are a common cause of allergic contact dermatitis. OBJECTIVE: To examine the prevalence of positive patch test reactions to isothiazolinones from 2017-2020 and characterize isothiazolinone-allergic (Is+) patients compared with isothiazolinone nonallergic (Is-) patients. METHODS: Retrospective cross-sectional analysis of 9028 patients patch tested to methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) 0.02% aqueous, MI 0.2% aqueous, benzisothiazolinone (BIT) 0.1% petrolatum, and/or octylisothiazolinone (OIT) 0.025% petrolatum. Prevalence, reaction strength, concurrent reactions, clinical relevance, and source of allergens were tabulated. RESULTS: In total, 21.9% (1976/9028) of patients had a positive reaction to 1 or more isothiazolinones. Positivity to MI was 14.4% (1296/9012), MCI/MI was 10.0% (903/9017), BIT was 8.6% (777/9018), and OIT was 05% (49/9028). Compared with Is-, Is+ patients were more likely to have occupational skin disease (16.5% vs 10.3%, P <.001), primary hand dermatitis (30.2% vs 19.7%, P <.001), and be >40 years (73.1% vs 61.9%, P <.001). Positive patch test reactions to >1 isothiazolinone occurred in 44.1% (871/1976) of Is+ patients. Testing solely to MCI/MI would miss 47.3% (611/1292) of MI and 60.1% (466/776) of BIT allergic reactions. LIMITATIONS: Retrospective cross-sectional study design and lack of follow-up data. CONCLUSION: Sensitization to isothiazolinones is high and concurrent sensitization to multiple isothiazolinone allergens is common.


Subject(s)
Dermatitis, Allergic Contact , Dermatitis, Occupational , Thiazoles , Humans , Cross-Sectional Studies , Retrospective Studies , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/epidemiology , Dermatitis, Allergic Contact/etiology , Dermatitis, Occupational/diagnosis , Dermatitis, Occupational/epidemiology , Dermatitis, Occupational/etiology , Allergens/adverse effects , North America , Patch Tests/adverse effects , Petrolatum , Preservatives, Pharmaceutical/adverse effects
2.
Contact Dermatitis ; 2024 Aug 21.
Article in English | MEDLINE | ID: mdl-39169428

ABSTRACT

BACKGROUND: Photoallergic contact dermatitis (PACD) is a delayed hypersensitivity reaction to allergens only in the presence of ultraviolet radiation in sunlight. Photopatch testing (PhotoPT) is necessary to confirm the diagnosis of PACD. There are few published studies of PhotoPT in North America. OBJECTIVE: To summarise the results of patients photopatch tested by members of the North American Contact Dermatitis Group (NACDG), 2009-2020. METHODS: Retrospective analysis of patient characteristics and PhotoPT results to 32 allergens on the NACDG Photopatch Test Series. RESULTS: Most of the 454 tested patients were female (70.3%), 21-60 years old (66.7%) and White (66.7%). There were a total of 119 positive photopatch tests. Sunscreen agents comprised 88.2% of those, with benzophenones responsible for over half of them. Final diagnoses included PACD in 17.2%, allergic contact dermatitis (ACD) in 44.5%, polymorphous light eruption (PMLE) in 18.9% and chronic actinic dermatitis (CAD) in 9.0% of patients. CONCLUSIONS: In 454 patients with suspected photosensitivity referred for photopatch testing in North America, approximately one-fifth had PACD. Sunscreen agents, especially benzophenones, were the most common photoallergens. Other common diagnoses included ACD, PMLE and CAD. Photopatch testing is an important tool for differentiating these conditions.

3.
Int J Toxicol ; 43(1_suppl): 64S-81S, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37930133

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 10 Ginkgo biloba-derived ingredients, which are most frequently reported to function in cosmetics as skin conditioning agents or antioxidants. The Panel reviewed the available data to determine the safety of these ingredients. Because final product formulations may contain multiple botanicals, each containing the same constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. The Panel was concerned about the presence of ginkgolic acid in cosmetics. Industry should use good manufacturing practices to limit impurities. The Panel concluded that 5 Ginkgo biloba leaf-derived ingredients are safe in the present practices of use and concentration described in this safety assessment when formulated to be non-sensitizing; data are insufficient to determine the safety of the remaining 5 ingredients under the intended conditions of use in cosmetic formulations.


Subject(s)
Cosmetics , Ginkgo biloba , Ginkgo biloba/toxicity , Consumer Product Safety , Plant Extracts/toxicity , Cosmetics/toxicity , Antioxidants
4.
Int J Toxicol ; 43(3_suppl): 135S-137S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38653732

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety reviewed newly available studies since their original assessment in 1982 and a previous re-review in 2002, along with updated information regarding product types and concentrations of use. Considering this information, the Panel confirmed that Laneth-9 Acetate and Laneth-10 Acetate are safe for topical application to humans in the present practices of use and concentration as described in this report.


Subject(s)
Acetates , Cosmetics , Animals , Humans , Acetates/toxicity , Acetates/pharmacokinetics , Consumer Product Safety , Cosmetics/toxicity
5.
Int J Toxicol ; 43(3_suppl): 138S-140S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38662440

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety reviewed newly available studies since their original assessment in 1986 and a previous re-review in 2004, along with updated information regarding product types and concentrations of use. Considering this information, the Panel confirmed that Zinc Phenolsulfonate is safe as a cosmetic ingredient in the present practices of use and concentration as described in this report.


Subject(s)
Cosmetics , Phenols , Sulfates , Zinc , Animals , Humans , Consumer Product Safety , Cosmetics/toxicity , Cosmetics/chemistry , Organometallic Compounds/toxicity , Risk Assessment , Toxicity Tests , Zinc/chemistry , Zinc/toxicity , Sulfates/chemistry , Sulfates/toxicity , Phenols/chemistry , Phenols/toxicity
6.
Int J Toxicol ; 43(3_suppl): 120S-127S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38471032

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Polysilicone-11 as used in cosmetic formulations. This ingredient is reported to function as a film former. The Panel considered the available data and concluded that Polysilicone-11 is safe in cosmetics in the present practices of use and concentration described in this safety assessment.


Subject(s)
Consumer Product Safety , Cosmetics , Cosmetics/toxicity , Cosmetics/chemistry , Humans , Animals , Risk Assessment , Toxicity Tests , Silicones/toxicity , Silicones/chemistry
7.
Int J Toxicol ; : 10915818241260280, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38872413

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) first published the Final Report of the safety of Isobutane, Isopentane, Butane, and Propane in 1982. The Panel previously concluded that these ingredients are considered safe as cosmetic ingredients under the present conditions of concentration and use, as described in that safety assessment. Upon re-review in 2002, the Panel reaffirmed the original conclusion, as published in 2005. The Panel reviewed update frequency and concentration of use data again in 2023, in addition to newly available, relevant safety data. Considering this information, as well as the information provided in the original safety assessment and the prior re-review document, the Panel reaffirmed the 1982 conclusion for Isobutane, Isopentane, Butane, and Propane.

8.
Int J Toxicol ; : 10915818241260276, 2024 Jun 24.
Article in English | MEDLINE | ID: mdl-38913451

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) first published a safety assessment of Sodium Dehydroacetate and Dehydroacetic Acid in 1985. The Panel previously concluded that Sodium Dehydroacetate and Dehydroacetic Acid are safe as used in the present practices of use and concentration, as stated in that report. Upon re-review in 2003, the Panel reaffirmed the original conclusion, as published in 2006. The Panel reviewed updated frequency and concentration of use data again in 2023, in addition to any newly available, relevant safety data. Considering this information, as well as the information provided in the original safety assessment and the prior re-review document, the Panel reaffirmed the 1985 conclusion.

9.
Int J Toxicol ; : 10915818241259694, 2024 Jul 23.
Article in English | MEDLINE | ID: mdl-39039928

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 10 alkanoyl lactyl lactate salts. These ingredients have the surfactant function in cosmetics in common. The Panel reviewed data relevant to the safety of these ingredients, and concluded that these 10 ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be nonirritating and nonsensitizing, which may be based on a quantitative risk assessment (QRA) or other accepted methodologies.

10.
Int J Toxicol ; : 10915818241267203, 2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39045851

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 30 vinylpyrrolidone polymers as used in cosmetic products; most of these ingredients have the reported cosmetic function of film former in common. The Panel reviewed data relevant to the safety of these ingredients, and determined that 27 vinylpyrrolidone polymers are safe in cosmetics in the present practices of use and concentration described in the safety assessment. The Panel also concluded that the available data are insufficient to make a determination that 3 vinylpyrrolidone polymers (all urethanes) are safe under the intended conditions of use in cosmetic formulations.

11.
Int J Toxicol ; : 10915818241259699, 2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39046084

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 10 polyol phosphates. Some of the possible functions in cosmetics that are reported for this ingredient group are chelating agents, oral care agents, and skin conditioning agents. The Panel reviewed relevant data relating to the safety of these ingredients under the intended conditions of use in cosmetic formulations, and concluded that Sodium Phytate, Phytic Acid, Phytin, and Trisodium Inositol Triphosphate are safe in cosmetics in the present practices of use and concentration described in the safety assessment. The Panel also concluded that the data are insufficient to determine the safety of the following 6 ingredients as used in cosmetics: Disodium Glucose Phosphate, Manganese Fructose Diphosphate, Sodium Mannose Phosphate, Trisodium Fructose Diphosphate, Xylityl Phosphate, and Zinc Fructose Diphosphate.

12.
Int J Toxicol ; : 10915818241260282, 2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39049435

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of three methylxanthines, Caffeine, Theobromine, and Theophylline, as used in cosmetics. All of these ingredients are reported to function as skin-conditioning agents in cosmetic products. The Panel reviewed the data relevant to the safety of these ingredients and concluded that Caffeine, Theobromine, and Theophylline are safe in cosmetics in the present practices of use and concentration described in this safety assessment.

13.
Int J Toxicol ; 43(3_suppl): 92S-108S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38465458

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reassessed the safety of Capryloyl Salicylic Acid in cosmetic products; this ingredient is reported to function as a skin conditioning agent. The Panel reviewed relevant data relating to the safety of this ingredient in cosmetic formulations, and concluded that the available data are insufficient to make a determination that Capryloyl Salicylic Acid is safe under the intended conditions of use in cosmetic formulations.


Subject(s)
Consumer Product Safety , Cosmetics , Salicylates , Animals , Humans , Cosmetics/toxicity , Cosmetics/chemistry , Risk Assessment , Salicylates/toxicity , Salicylates/pharmacokinetics , Salicylic Acid/toxicity , Salicylic Acid/pharmacokinetics , Salicylic Acid/chemistry , Toxicity Tests
14.
Int J Toxicol ; 43(3_suppl): 128S-134S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38465394

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Hydroxyethyl Urea, which is reported to function as a humectant and a hair and skin conditioning agent. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Hydroxyethyl Urea is safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be non-irritating.


Subject(s)
Consumer Product Safety , Cosmetics , Urea , Animals , Humans , Cosmetics/toxicity , Cosmetics/chemistry , Cosmetics/pharmacokinetics , Risk Assessment , Toxicity Tests , Urea/analogs & derivatives , Urea/toxicity
15.
Int J Toxicol ; 43(3_suppl): 109S-119S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38471901

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Basic Red 76, which is reported to function in cosmetics as a hair colorant and hair-conditioning agent. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Basic Red 76 is safe for use as a hair dye ingredient in the present practices of use and concentration described in the safety assessment.


Subject(s)
Consumer Product Safety , Cosmetics , Hair Dyes , Animals , Humans , Rats , Cosmetics/toxicity , Cosmetics/chemistry , Hair Dyes/toxicity , Hair Dyes/chemistry , Hair Dyes/pharmacokinetics , Risk Assessment , Toxicity Tests
16.
Int J Toxicol ; 43(2_suppl): 5S-69S, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38279815

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 27 inorganic and organometallic zinc salts as used in cosmetic formulations; these salts are specifically of the 2+ (II) oxidation state cation of zinc. These ingredients included in this report have various reported functions in cosmetics, including hair conditioning agents, skin conditioning agents, cosmetic astringents, cosmetic biocides, preservatives, oral care agents, buffering agents, bulking agents, chelating agents, and viscosity increasing agents. The Panel reviewed the relevant data for these ingredients, and concluded that these 27 ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating.


Subject(s)
Cosmetics , Dermatologic Agents , Salts , Consumer Product Safety , Cosmetics/toxicity , Chelating Agents/toxicity , Risk Assessment
17.
Int J Toxicol ; : 10915818241259692, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38872392

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Triphenyl Phosphate, which is reported to function as a plasticizer in manicuring products. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Triphenyl Phosphate is safe in cosmetics in the present practices of use and concentration described in this safety assessment.

18.
Int J Toxicol ; 43(3_suppl): 64S-91S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38485254

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 8 palm tree (Euterpe edulis (juçara) and Euterpe oleracea (açaí))-derived ingredients as used in cosmetic products; these ingredients are reported to function mostly as skin conditioning agents. The Panel reviewed relevant data relating to the safety of these ingredients in cosmetic formulations. Industry should continue to use good manufacturing practices to limit impurities. The Panel concluded that palm tree (açaí and juçara)-derived ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment.


Subject(s)
Consumer Product Safety , Cosmetics , Cosmetics/toxicity , Cosmetics/chemistry , Humans , Animals , Euterpe/chemistry , Euterpe/toxicity , Toxicity Tests , Risk Assessment
19.
Int J Toxicol ; : 10915818241231249, 2024 Feb 11.
Article in English | MEDLINE | ID: mdl-38342963

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 28 soy-derived ingredients as used in cosmetic products. These ingredients are reported to primarily function as antioxidants, skin protectants, skin-conditioning agents, and hair-conditioning agents. The Panel considered the available data relating to the safety of these ingredients in cosmetic formulations, and concluded that 24 of the 28 soy-derived ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment. The Panel also concluded that the available data are insufficient to make a determination that Glycine Max (Soybean) Callus Culture, Glycine Max (Soybean) Callus Culture Extract, Glycine Max (Soybean) Callus Extract, and Glycine Max (Soybean) Phytoplacenta Conditioned Media are safe under the intended conditions of use in cosmetic formulations.

20.
Int J Toxicol ; 43(2_suppl): 70S-131S, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38174390

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 10 alkane diol ingredients as used in cosmetics. The alkane diols are structurally related to each other as small diols, and most are reported to function in cosmetics as solvents. The Panel reviewed the relevant data for these ingredients, and concluded that seven alkane diols are safe in cosmetics in the present practices of use and concentration described in this safety assessment, but that the available data are insufficient to make a determination of safety for three ingredients, namely 1,4-Butanediol, 2,3-Butanediol, and Octanediol.


Subject(s)
Consumer Product Safety , Cosmetics , Cosmetics/toxicity , Alcohols , Solvents , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL